Sun Pharma Advanced Research Company, 532872, SPARC Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,761.40
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,829.29
N/A
-104.79

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.79
-13.79
-0.62

EBITDA CAGR (%)

10 Years
5 Years
3 Years

46.89
37.45
5.03

PAT CAGR (%)

10 Years
5 Years
3 Years

43.39
34.88
16.61

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

-12.75
-12.75
-12.75

EV:EBITDA (Average)

8 Years
5 Years
3 Years

1.82
-37.24
-30.34

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 17.64 17.19 2.62% 185.45 17.32 970.73% 22.71 84.83 -73.23% 19.60 19.88 -1.41%
Expenses 100.01 80.11 24.84% 124.67 112.34 10.98% 121.07 96.75 25.14% 73.31 90.26 -18.78%
EBITDA -82.37 -62.92 - 60.78 -95.02 - -98.36 -11.92 - -53.71 -70.38 -
EBIDTM -466.95% -366.03% 32.77% -548.61% -0.29% -0.29% -274.03% -354.02%
Other Income 2.82 2.26 24.78% 0.66 3.67 -82.02% 3.12 4.43 -29.57% 0.71 3.27 -78.29%
Interest 1.16 0.25 364.00% 1.97 0.59 233.90% 1.57 0.04 3,825.00% 0.26 0.02 1,200.00%
Depreciation 2.78 2.25 23.56% 2.78 2.25 23.56% 2.73 1.82 50.00% 2.25 1.90 18.42%
PBT -83.49 -63.16 - 56.69 -94.19 - -99.54 -9.35 - -55.51 -69.03 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -83.49 -63.16 - 56.69 -94.19 - -99.54 -9.35 - -55.51 -69.03 -
PATM -473.30% -367.42% 30.57% -543.82% 2.87% 2.87% -283.21% -347.23%
EPS -3.19 -2.41 - 2.16 -3.60 - -3.80 -0.36 - -2.12 -2.63 -

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 245.40 76.81 182.87 78.26 181.02 161.28 155.74 167.03 87.28 28.98 58.35 Net Sales Growth 76.27% -58.00% 133.67% -56.77% 12.24% 3.56% -6.76% 91.37% 201.17% -50.33% Cost Of Goods Sold 514.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit -269.04 76.81 182.87 78.26 181.02 161.28 155.74 167.03 87.28 28.98 58.35 GP Margin -109.63% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 419.06 386.83 334.16 320.87 303.72 224.48 190.83 133.54 104.04 98.92 64.98 Power & Fuel Cost - 5.14 5.08 4.92 4.67 4.49 4.78 3.95 3.85 3.35 2.76 % Of Sales - 6.69% 2.78% 6.29% 2.58% 2.78% 3.07% 2.36% 4.41% 11.56% 4.73% Employee Cost - 93.09 81.06 100.92 84.30 56.60 45.79 40.40 36.55 30.43 25.67 % Of Sales - 121.20% 44.33% 128.95% 46.57% 35.09% 29.40% 24.19% 41.88% 105.00% 43.99% Manufacturing Exp. - 30.47 17.81 31.79 33.41 26.42 17.96 16.19 15.84 12.99 13.07 % Of Sales - 39.67% 9.74% 40.62% 18.46% 16.38% 11.53% 9.69% 18.15% 44.82% 22.40% General & Admin Exp. - 251.32 221.40 181.18 176.28 131.88 119.37 71.71 46.26 51.31 22.72 % Of Sales - 327.20% 121.07% 231.51% 97.38% 81.77% 76.65% 42.93% 53.00% 177.05% 38.94% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 6.81 8.80 2.05 5.06 5.08 2.94 1.29 1.54 0.85 0.00 % Of Sales - 8.87% 4.81% 2.62% 2.80% 3.15% 1.89% 0.77% 1.76% 2.93% 1.30% EBITDA -173.66 -310.02 -151.29 -242.61 -122.70 -63.20 -35.09 33.49 -16.76 -69.94 -6.63 EBITDA Margin -70.77% -403.62% -82.73% -310.01% -67.78% -39.19% -22.53% 20.05% -19.20% -241.34% -11.36% Other Income 7.31 9.76 13.51 4.94 13.72 2.94 3.03 10.00 1.62 1.15 1.24 Interest 4.96 2.67 0.09 0.12 1.82 2.16 0.22 5.60 3.95 0.27 0.13 Depreciation 10.54 9.48 7.55 8.18 8.24 7.58 7.24 3.57 3.40 3.16 2.99 PBT -181.85 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 -72.23 -8.51 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.00 0.00 0.00 -0.01 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.66% 0.00% 0.00% 0.12% PAT -181.85 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 -72.23 -8.50 PAT before Minority Interest -181.85 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 -72.23 -8.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -74.10% -406.72% -79.53% -251.73% -65.76% -43.40% -25.38% 18.15% -25.77% -249.24% -14.57% PAT Growth 0.00% - - - - - - - - - EPS -6.94 -11.92 -5.55 -7.52 -4.54 -2.67 -1.51 1.16 -0.86 -2.76 -0.32

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds -18.64 296.24 184.72 158.16 31.80 99.80 139.30 108.43 -66.61 5.62 Share Capital 26.21 26.21 25.09 24.69 23.67 23.67 23.67 23.66 20.71 20.71 Total Reserves -44.84 270.03 67.96 133.47 6.23 76.13 115.63 84.77 -87.32 -15.09 Non-Current Liabilities 55.85 7.20 11.98 10.36 10.02 9.72 9.45 6.32 7.23 7.48 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 6.38 1.09 1.64 2.18 2.73 3.27 3.82 4.36 5.74 6.30 Long Term Provisions 10.23 6.11 10.34 8.18 7.30 6.37 5.48 1.73 1.24 1.06 Current Liabilities 235.36 95.04 116.11 108.03 124.84 37.15 38.79 94.24 145.03 64.66 Trade Payables 158.84 82.92 102.48 94.45 58.15 27.01 29.75 12.79 16.23 10.31 Other Current Liabilities 9.78 7.66 9.42 9.81 12.09 8.98 7.58 3.79 66.06 53.17 Short Term Borrowings 61.42 0.00 0.10 0.41 52.48 0.40 0.82 75.97 61.94 0.29 Short Term Provisions 5.31 4.46 4.10 3.35 2.12 0.77 0.64 1.69 0.79 0.89 Total Liabilities 272.57 398.48 312.81 276.55 166.66 146.67 187.54 208.99 85.65 77.76 Net Block 103.86 57.56 51.74 69.16 69.96 66.79 64.49 65.55 63.93 62.93 Gross Block 135.50 80.22 67.17 77.28 106.82 96.38 86.98 84.57 79.58 75.45 Accumulated Depreciation 31.64 22.66 15.44 8.12 36.86 29.58 22.49 19.02 15.65 12.52 Non Current Assets 205.38 141.09 137.59 118.27 98.88 83.46 76.87 69.14 66.97 65.27 Capital Work in Progress 32.07 24.13 3.27 1.47 0.87 0.02 0.76 0.16 1.14 1.26 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 69.24 59.29 82.48 47.45 27.99 16.55 11.50 3.30 1.69 0.89 Other Non Current Assets 0.20 0.12 0.10 0.19 0.07 0.09 0.11 0.13 0.21 0.19 Current Assets 67.19 257.38 175.22 158.28 66.59 62.93 110.12 139.01 18.24 12.50 Current Investments 8.49 210.58 107.57 9.65 0.00 0.00 6.50 96.91 0.00 2.47 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 16.05 10.17 17.56 38.90 9.16 19.89 28.00 25.06 4.26 2.63 Cash & Bank 0.46 0.68 1.32 70.31 12.75 17.34 6.56 6.72 6.50 5.15 Other Current Assets 42.19 2.57 2.04 1.95 44.69 25.70 69.06 10.33 7.48 2.25 Short Term Loans & Adv. 39.33 33.39 46.73 37.48 43.35 24.27 63.34 9.69 7.15 2.02 Net Current Assets -168.17 162.34 59.11 50.25 -58.24 25.79 71.33 44.77 -126.79 -52.16 Total Assets 272.57 398.47 312.81 276.55 166.65 146.67 187.55 208.99 85.64 77.77

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -210.81 -171.91 -182.77 -128.04 -44.21 -41.17 36.90 -95.34 -69.45 2.29 PBT -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 -72.23 -8.51 Adjustment 9.44 -21.77 3.82 -1.14 9.25 4.73 0.90 5.71 2.87 2.70 Changes in Working Capital 102.02 -0.17 20.48 12.86 30.41 -3.74 9.80 -77.91 0.70 8.14 Cash after chg. in Working capital -200.95 -167.38 -221.68 -107.32 -30.34 -38.53 45.03 -94.69 -68.66 2.33 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -9.86 -4.54 -10.08 -20.72 -13.87 -2.64 -8.13 -0.65 -0.79 -0.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 48.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 155.35 -102.19 -104.62 -6.61 -13.08 53.00 43.59 -99.31 -2.42 -7.64 Net Fixed Assets -63.22 -33.91 8.31 28.94 -11.29 -8.66 -3.01 -4.01 -4.01 -4.15 Net Investments 202.09 -103.01 -97.92 -9.65 0.00 6.50 90.41 -96.91 2.47 -2.47 Others 16.48 34.73 -15.01 -25.90 -1.79 55.16 -43.81 1.61 -0.88 -1.02 Cash from Financing Activity 55.46 274.25 224.01 194.25 50.55 -1.26 -80.84 194.38 72.10 4.41 Net Cash Inflow / Outflow 0.00 0.15 -63.38 59.60 -6.74 10.57 -0.35 -0.27 0.23 -0.93 Opening Cash & Equivalents 0.35 0.20 63.58 4.00 10.63 0.01 0.33 0.57 0.34 1.27 Closing Cash & Equivalent 0.35 0.35 0.20 63.58 4.00 10.63 0.01 0.33 0.57 0.34

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) -0.71 11.30 3.71 6.41 1.21 4.18 5.82 4.52 -3.16 0.27 ROA -93.11% -40.89% -66.85% -53.72% -44.68% -23.65% 15.29% -15.27% -88.40% -11.33% ROE -225.08% -74.72% -156.84% -127.40% -109.16% -33.17% 24.62% -110.94% 0.00% -86.09% ROCE -178.22% -59.95% -113.05% -94.66% -71.37% -31.74% 24.02% -19.55% -1066.48% -58.87% Fixed Asset Turnover 0.71 2.48 1.08 1.97 1.59 1.70 1.95 1.06 0.37 0.80 Receivable days 62.28 27.67 131.66 48.45 32.87 56.11 57.97 61.31 43.42 9.80 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 316.55 300.15 244.72 211.37 163.03 136.14 120.80 88.65 96.96 87.32 Cash Conversion Cycle -254.27 -272.48 -113.05 -162.92 -130.16 -80.03 -62.83 -27.34 -53.54 -77.52 Total Debt/Equity -3.67 0.01 0.02 0.02 1.94 0.04 0.04 0.75 -1.02 1.17 Interest Cover -115.79 -1547.78 -1596.71 -64.41 -31.45 -180.04 7.13 -4.69 -261.76 -65.47

Top Investors:

sun pharmaceutical industries key employees benefit trust

lakshdeep investments & finance (p) ltd.

Annual Reports:

News Update:

Sun Pharma Advanced Research’s net loss widens to Rs 83 crore in Q2
10th Nov 2020, 11:57 AM

Total income of the company increased 5.19% at Rs 20.46 crore for Q2FY21
Read More
Sun Pharma Advanced reports positive top-line results for investigational drug ‘SDN-037’
14th Oct 2020, 11:02 AM

The objective of the trial was to assess the efficacy and safety of SDN-037 in clearing the inflammation and pain
Read More
SPARC grants exclusive license to Tripoint Therapeutics LLC, USA
22nd Sep 2020, 09:38 AM

The company will be eligible to receive tiered royalties ranging from 15% to 50% on net sales
Read More

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532872 | NSE: SPARC

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532872 | NSE: SPARC

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: